If an oral obesity treatment drug were actually released, would you be willing to take it?

If the oral obesity treatment currently under development by Samchundang Pharmaceutical is actually released, would you be willing to take it?
Unlike Wigobi, which is in injectable form, Samchundang Pharmaceutical is reportedly developing an oral formulation that allows the injectable ingredients to be taken as a pill.
It is characterized by the application of proprietary S-PASS platform technology, designed to prevent drug destruction by stomach acid and ensure effective absorption in the intestines.
It is attracting a lot of attention as the convenience of administration has been dramatically improved compared to existing injectables.
There is also growing anticipation that it will become a new alternative for obesity treatment, as it can alleviate the inconvenience and pain burden of injections.
However, given the characteristics of the oral formulation, one might wonder how it differs from the injectable form in terms of absorption rate and gastrointestinal side effects.
I am curious to hear the honest thoughts of those who usually feel burdened by injectable treatments or existing users.
If an oral formulation becomes commercialized, do you plan to switch to taking it instead of the existing injectable?
We would appreciate it if you could share your valuable opinions regarding the efficacy, convenience, and expected aspects of oral obesity treatments.